231 related articles for article (PubMed ID: 25587178)
1. Does reduction of disease activity improve early markers of cardiovascular disease in newly diagnosed rheumatoid arthritis patients?
de Groot L; Jager NA; Westra J; Smit AJ; Kallenberg CG; Posthumus MD; Bijl M
Rheumatology (Oxford); 2015 Jul; 54(7):1257-61. PubMed ID: 25587178
[TBL] [Abstract][Full Text] [Related]
2. Advanced glycation endproducts are increased in rheumatoid arthritis patients with controlled disease.
de Groot L; Hinkema H; Westra J; Smit AJ; Kallenberg CG; Bijl M; Posthumus MD
Arthritis Res Ther; 2011; 13(6):R205. PubMed ID: 22168993
[TBL] [Abstract][Full Text] [Related]
3. Is small artery elasticity decreased prior to intima-media thickening in patients with longstanding rheumatoid arthritis?
Hinkema HJ; Nienhuis HL; de Groot L; Smit AJ; van Roon AM; Bijl M; Posthumus MD
J Rheumatol; 2011 Oct; 38(10):2133-40. PubMed ID: 21844153
[TBL] [Abstract][Full Text] [Related]
4. Advanced glycation end-products inhibition improves endothelial dysfunction in rheumatoid arthritis.
Syngle A; Vohra K; Garg N; Kaur L; Chand P
Int J Rheum Dis; 2012 Feb; 15(1):45-55. PubMed ID: 22324946
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis.
Dessein PH; Joffe BI; Singh S
Arthritis Res Ther; 2005; 7(3):R634-43. PubMed ID: 15899050
[TBL] [Abstract][Full Text] [Related]
6. [Markers of endothelial activation in rheumatoid arthritis].
Shilikina NP; Yunonin IE; Vinogradov AA; Butusova SV
Ter Arkh; 2012; 84(8):29-32. PubMed ID: 22994085
[TBL] [Abstract][Full Text] [Related]
7. Effects of disease modifying anti-rheumatic drugs on subclinical atherosclerosis and endothelial dysfunction which has been detected in early rheumatoid arthritis: 1-year follow-up study.
Guin A; Chatterjee Adhikari M; Chakraborty S; Sinhamahapatra P; Ghosh A
Semin Arthritis Rheum; 2013 Aug; 43(1):48-54. PubMed ID: 23415602
[TBL] [Abstract][Full Text] [Related]
8. Biochemical and biophysical markers of endothelial dysfunction in adults with hypopituitarism and severe GH deficiency.
Elhadd TA; Abdu TA; Oxtoby J; Kennedy G; McLaren M; Neary R; Belch JJ; Clayton RN
J Clin Endocrinol Metab; 2001 Sep; 86(9):4223-32. PubMed ID: 11549653
[TBL] [Abstract][Full Text] [Related]
9. Advanced glycation end-product peptides are associated with impaired renal function, but not with biochemical markers of endothelial dysfunction and inflammation, in non-diabetic individuals.
Stam F; Schalkwijk CG; van Guldener C; ter Wee PM; Stehouwer CD
Nephrol Dial Transplant; 2006 Mar; 21(3):677-82. PubMed ID: 16330467
[TBL] [Abstract][Full Text] [Related]
10. Effects of adalimumab treatment on vascular disease associated with early rheumatoid arthritis.
Kerekes G; Soltész P; Szucs G; Szamosi S; Dér H; Szabó Z; Csáthy L; Váncsa A; Szodoray P; Szegedi G; Szekanecz Z
Isr Med Assoc J; 2011 Mar; 13(3):147-52. PubMed ID: 21608334
[TBL] [Abstract][Full Text] [Related]
11. The Extent of Subclinical Atherosclerosis Is Partially Predicted by the Inflammatory Load: A Prospective Study over 5 Years in Patients with Rheumatoid Arthritis and Matched Controls.
Södergren A; Karp K; Bengtsson C; Möller B; Rantapää-Dahlqvist S; Wållberg-Jonsson S
J Rheumatol; 2015 Jun; 42(6):935-42. PubMed ID: 25877503
[TBL] [Abstract][Full Text] [Related]
12. Inflammation and microvascular and macrovascular endothelial dysfunction in rheumatoid arthritis: effect of treatment.
Foster W; Carruthers D; Lip GY; Blann AD
J Rheumatol; 2010 Apr; 37(4):711-6. PubMed ID: 20156948
[TBL] [Abstract][Full Text] [Related]
13. Biomarkers of endothelial dysfunction in patients with primary focal segmental glomerulosclerosis.
Zhang Q; Zeng C; Fu Y; Cheng Z; Zhang J; Liu Z
Nephrology (Carlton); 2012 May; 17(4):338-45. PubMed ID: 22295953
[TBL] [Abstract][Full Text] [Related]
14. Traditional risk factor assessment does not capture the extent of cardiovascular risk in systemic lupus erythematosus.
Lee AB; Godfrey T; Rowley KG; Karschimkus CS; Dragicevic G; Romas E; Clemens L; Wilson AM; Nikpour M; Prior DL; Best JD; Jenkins AJ
Intern Med J; 2006 Apr; 36(4):237-43. PubMed ID: 16640741
[TBL] [Abstract][Full Text] [Related]
15. Effect of etanercept on serum levels of soluble cell adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) and vascular endothelial growth factor in patients with rheumatoid arthritis.
Klimiuk PA; Sierakowski S; Domyslawska I; Chwiecko J
Scand J Rheumatol; 2009; 38(6):439-44. PubMed ID: 19922018
[TBL] [Abstract][Full Text] [Related]
16. Reduced arterial elasticity in rheumatoid arthritis and the relationship to vascular disease risk factors and inflammation.
Wong M; Toh L; Wilson A; Rowley K; Karschimkus C; Prior D; Romas E; Clemens L; Dragicevic G; Harianto H; Wicks I; McColl G; Best J; Jenkins A
Arthritis Rheum; 2003 Jan; 48(1):81-9. PubMed ID: 12528107
[TBL] [Abstract][Full Text] [Related]
17. Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy.
Mäki-Petäjä KM; Hall FC; Booth AD; Wallace SM; Yasmin ; Bearcroft PW; Harish S; Furlong A; McEniery CM; Brown J; Wilkinson IB
Circulation; 2006 Sep; 114(11):1185-92. PubMed ID: 16952987
[TBL] [Abstract][Full Text] [Related]
18. Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis and Low Cardiovascular Risk: The Role of von Willebrand Factor Activity.
Ristić GG; Subota V; Lepić T; Stanisavljević D; Glišić B; Ristić AD; Petronijević M; Stefanović DZ
PLoS One; 2015; 10(8):e0130462. PubMed ID: 26247590
[TBL] [Abstract][Full Text] [Related]
19. Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity.
Kerekes G; Szekanecz Z; Dér H; Sándor Z; Lakos G; Muszbek L; Csipö I; Sipka S; Seres I; Paragh G; Kappelmayer J; Szomják E; Veres K; Szegedi G; Shoenfeld Y; Soltész P
J Rheumatol; 2008 Mar; 35(3):398-406. PubMed ID: 18203326
[TBL] [Abstract][Full Text] [Related]
20. Angiopoietin-2 is highly correlated with inflammation and disease activity in recent-onset rheumatoid arthritis and could be predictive for cardiovascular disease.
Westra J; de Groot L; Plaxton SL; Brouwer E; Posthumus MD; Kallenberg CG; Bijl M
Rheumatology (Oxford); 2011 Apr; 50(4):665-73. PubMed ID: 21131273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
